Use of capecitabine in refractory metastatic medullary thyroid carcinoma

Thyroid

Volumn 18, Issue 5, 2008, Pages 587-

  Paiva, Carlos Eduardo ^a   Michelin, Odair Carlito ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL;

ADULT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; HUMAN; LETTER; LYMPH NODE DISSECTION; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, MEDULLARY; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; MALE; NEOPLASM METASTASIS; THYROID NEOPLASMS;

EID: 43449124120     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0220     Document Type: Letter

References (5)

1. National Comprehensive Cancer Center Network Clinical Practice Guidelines in Oncology: Thyroid Carcinoma. Version 2.2007. 〈http://www.nccn.org/ professionals/physician_gls/PDF/thyroid.pdf〉. Accessed June 11, 2007.
2. Martins RG, Rajendran JG, Capell P, Byrd DR, Mankoff DA 2006 Medullary thyroid cancer: options for systemic therapy of metastatic disease? J Clin Oncol 11:1653-1655.
3. Nocera M, Baudin E, Pellegriti G, Cailleux AF, Mechelany-Corone C, Schlumberger M 2000 Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs a Calcitonine (GETC). Br J Cancer 83:715-718.
4. Kober F, Hermann M, Handler A, Krotla G 2007 Effect of sorafenib in symptomatic metastatic medullary thyroid cancer. Proc Am Soc Clin Oncol 25:14065.
5. Gilliam LK, Kohn AM, Lalani T, Swanson PE, Vasko V, Patel A, Livingston RB, Pickett CA 2006 Capecitabine therapy for refractory metastatic thyroid carcinoma: a case series. Thyroid 16:801-810.